Range Financial Group LLC acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 16,159 shares of the technology company's stock, valued at approximately $1,376,000.
Several other institutional investors and hedge funds have also recently modified their holdings of DOX. Sargent Investment Group LLC purchased a new position in shares of Amdocs in the second quarter valued at $289,000. Mirabella Financial Services LLP increased its holdings in shares of Amdocs by 204.2% in the 3rd quarter. Mirabella Financial Services LLP now owns 14,302 shares of the technology company's stock worth $1,250,000 after buying an additional 9,600 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in shares of Amdocs by 34.7% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company's stock valued at $12,733,000 after buying an additional 37,516 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Amdocs by 1.9% in the 3rd quarter. Victory Capital Management Inc. now owns 478,137 shares of the technology company's stock valued at $41,827,000 after acquiring an additional 9,098 shares during the last quarter. Finally, Vaughan David Investments LLC IL grew its position in Amdocs by 5.5% in the second quarter. Vaughan David Investments LLC IL now owns 405,252 shares of the technology company's stock worth $31,982,000 after acquiring an additional 21,157 shares in the last quarter. Institutional investors own 92.02% of the company's stock.
Amdocs Trading Down 0.3 %
Shares of NASDAQ DOX traded down $0.29 during mid-day trading on Tuesday, reaching $84.18. The company had a trading volume of 478,589 shares, compared to its average volume of 484,322. The stock has a market cap of $9.50 billion, a price-to-earnings ratio of 19.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.71. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04. The business's 50-day moving average is $87.03 and its 200-day moving average is $85.57. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21.
Amdocs Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Amdocs's dividend payout ratio (DPR) is presently 45.05%.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the company. StockNews.com raised Amdocs from a "buy" rating to a "strong-buy" rating in a research note on Monday. Stifel Nicolaus started coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price objective for the company. Barclays reduced their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a research note on Thursday, November 14th. Finally, Oppenheimer lifted their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Amdocs presently has an average rating of "Buy" and an average target price of $101.20.
Read Our Latest Analysis on DOX
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.